Toxicidad por suplementos no regulados: caracterización clínica y alertas sanitarias
Salud y Expectativas · 12.05.2026 · 4 (2) · 57-76
DOI: 10.70577/8saqx322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Salud y Expectativas, online erschienen am 12.05.2026. Verfasst von Diego Andres Merchan Ponce. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
The increasing commercialization of unregulated dietary supplements has generated a significant public health concern due to the presence of undeclared pharmacologically active substances and deficiencies in regulatory traceability, leading to potentially severe adverse events and recurrent institutional alerts. Within this framework, the objective of this study was to clinically characterize toxicity associated with these products and to analyze the regulatory patterns underlying official health alerts issued between 2021 and 2023 by national and international authorities. An observational analytical design with a retrospective approach was conducted using official secondary data sources. Advanced descriptive statistics, multivariate logistic regression, and LASSO penalized regression were applied to identify predictors associated with the presence of undeclared substances. The findings revealed a statistically significant association between sexual enhancement claims and the detection of phosphodiesterase type 5 inhibitors, as well as between weight loss claims and the presence of sibutramine, confirming a structural pattern of pharmacological adulteration. Advanced modeling techniques allowed the identification of high-impact predictive variables, strengthening risk-based surveillance strategies. From a public health perspective, the results underscore the need to consolidate predictive control systems, reinforce pre-market regulatory oversight, and enhance the integration of clinical evidence with regulatory response to mitigate inadvertent population exposure to high-risk compounds.
Zitieren
APA
Ponce, D. A. M. (2026). Toxicidad por suplementos no regulados: caracterización clínica y alertas sanitarias. Salud y Expectativas, 4(2), 57-76. https://doi.org/10.70577/8saqx322
Vancouver
Ponce DAM. Toxicidad por suplementos no regulados: caracterización clínica y alertas sanitarias. Salud y Expectativas. 2026;4(2):57-76. doi:10.70577/8saqx322
BibTeX
@article{Ponce2026,
author = {Ponce, Diego Andres Merchan},
title = {Toxicidad por suplementos no regulados: caracterización clínica y alertas sanitarias},
journal = {Salud y Expectativas},
year = {2026},
volume = {4},
number = {2},
pages = {57--76},
doi = {10.70577/8saqx322}
}
EUVIMED